Healthcare - Biotechnology - NASDAQ - US
$ 3.46
2.98 %
$ 173 M
Market Cap
-2.22
P/E
CASH FLOW STATEMENT
-59.2 M
OPERATING CASH FLOW
20 M
INVESTING CASH FLOW
14.8 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
scPharmaceuticals Inc.
| Net Income | -54.8 M |
| Depreciation & Amortization | 626 K |
| Capital Expenditures | -40 K |
| Stock-Based Compensation | 4.86 M |
| Change in Working Capital | -6.32 M |
| Others | -3.37 M |
| Free Cash Flow | -59.3 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | |
|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||
| Net Income | (54.8) | (36.8) | (28.0) | (32.2) | (33.0) | (29.4) | (23.8) | (24.4) | (10.5) |
| Depreciation & Amortization | 0.6 | 0.5 | 0.4 | 0.4 | 0.4 | 0.3 | 0.2 | 5 K | 4 K |
| Deferred Income Tax | 0 | 0 | 0 | 30 K | 2 K | 0 | 0 | 0 | 0 |
| Stock Based Compensation | 4.9 | 2.8 | 2.4 | 2.0 | 1.4 | 2.1 | 0.9 | 0.9 | 0.4 |
| Other Operating Activities | (3.6) | (0.7) | 0.7 | 0.6 | 0.4 | 0.4 | 0.2 | 6.5 | (0.4) |
| Change in Working Capital | (6.3) | (0.3) | (2.6) | 1.4 | 0.4 | (2.2) | (0.2) | 1.5 | 0.9 |
| Cash From Operations | (59.2) | (34.6) | (27.2) | (27.7) | (30.4) | (28.8) | (22.7) | (15.5) | (9.6) |
| INVESTING CASH FLOW | |||||||||
| Capital Expenditures | 40 K | 21 K | 9 K | 0 | 0 | 0 | (0.2) | 9 K | 17 K |
| Other Items | 20.0 | (45.8) | 32.1 | (33.5) | 0 | 0 | 0 | 0 | 0 |
| Cash From Investing Activities | 20.0 | (45.9) | 32.1 | (33.5) | 0 | 0 | (0.2) | 9 K | 17 K |
| FINANCING CASH FLOW | |||||||||
| Common Stock Repurchased | 0 | 0 | 81 K | (0.2) | 0 | 4 K | 3 K | 0 | 9 K |
| Total Debt Repaid | 0 | 29.8 | (2.5) | 0 | 9.6 | 62 K | 9.3 | 12.6 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 0.8 | (0.3) | 81 K | (0.2) | 60 K | 58 K | 94 K | 40.6 | 8.0 |
| Cash From Financing Activities | 14.8 | 77.2 | (2.5) | 60.3 | 13.6 | 8 K | 102.1 | 53.2 | 8.0 |
| CHANGE IN CASH | |||||||||
| Net Change In Cash | (24.4) | (3.2) | 2.4 | (0.8) | (16.9) | (28.8) | 79.2 | 37.7 | (1.6) |
| FREE CASH FLOW | |||||||||
| Free Cash Flow | (59.3) | (34.6) | (27.2) | (27.7) | (30.4) | (28.8) | (22.9) | (15.5) | (9.7) |